SEARCH

SEARCH BY CITATION

References

  • Antin, J.H., Weinberg, D.S. & Rosenthal, D.S. (1990) Variable effect of recombinant human granulocyte-macrophage colony-stimulating factor on bone marrow fibrosis in patients with myelodysplasia. Experimental Hematology, 18, 266270.
  • Bain, B.J., Clark, D.M., Lampert, I.A. & Wilkins, B.S. (2001) Bone Marrow Pathology. 2nd Edition. Blackwell Science Ltd, London.
  • Bancroft, J.D. & Gamble, M. (2002) Theory and Practice of Histological Techniques. Churchill-Livingstone, London.
  • Barosi, G. (1999) Myelofibrosis with myeloid metaplasia: diagnostic definition and prognostic classification for clinical studies and treatment guidelines. Journal of Clinical Oncology, 17, 29542970.
  • Barosi, G., Bordessoule, D., Briere, J., Cervantes, F., Demory, J.L., Dupriez, B., Gisslinger, H., Griesshammer, M., Hasselbalch, H., Kusec, R., Le Bousse-Kerdiles, M.C., Liberato, N.L., Marchetti, M., Reilly, J.T. & Thiele, J. (2005) Response criteria for myelofibrosis with myeloid metaplasia: results of an initiative of the European Myelofibrosis Network (EUMNET). Blood, 106, 28492853.
  • Bass, R.D., Pullarkat, V., Feinstein, D.I., Kaul, A., Winberg, C.D. & Brynes, R.K. (2001) Pathology of autoimmune myelofibrosis. A report of three cases and a review of the literature. American Journal of Clinical Pathology, 116, 211216.
  • Bauermeister, D.E. (1971) Quantitation of bone marrow reticulin – a normal range. American Journal of Clinical Pathology, 56, 2431.
  • Beckman, E.N. & Brown, A.W., (1990) Normal reticulin level in iliac bone marrow. Archives of Pathology & Laboratory Medicine, 114, 12411243.
  • Beham-Schmid, C., Apfelbeck, U., Sill, H., Tsybrovsky, O., Hofler, G., Haas, O.A. & Linkesch, W. (2002) Treatment of chronic myelogenous leukemia with the tyrosine kinase inhibitor STI571 results in marked regression of bone marrow fibrosis. Blood, 99, 381383.
  • Bentley, S.A., Alabaster, O. & Foidart, J.M. (1981) Collagen heterogeneity in normal human bone marrow. British Journal of Haematology, 48, 287291.
  • Bock, O., Neuse, J., Hussein, K., Brakensiek, K., Buesche, G., Buhr, T., Wiese, B. & Kreipe, H. (2006) Aberrant collagenase expression in chronic idiopathic myelofibrosis is related to the stage of disease but not to the JAK2 mutation status. American Journal of Pathology, 169, 471481.
  • Bussel, J.B., Kuter, D.J., George, J.N., McMillan, R., Aledort, L.M., Conklin, G.T., Lichtin, A.E., Lyons, R.M., Nieva, J., Wasser, J.S., Wiznitzer, I., Kelly, R., Chen, C.F. & Nichol, J.L. (2006a) AMG 531, a thrombopoiesis-stimulating protein, for chronic ITP. New England Journal of Medicine, 355, 16721681.
  • Bussel, J., Cheng, G., Saleh, M., Kovaleva, L., Stone, N., Mayer, B., Jenkins, J. & Provan, A. (2006b) Analysis of bleeding in patients with immune thrombocytopenic purpura (ITP): a randomized, double-blind, placebo-controlled trial of eltrombopag, an oral platelet growth factor. Blood, 108, 144a.
  • Castro-Malaspina, H., Rabellino, E.M., Yen, A., Nachman, R.L. & Moore, M.A. (1981) Human megakaryocyte stimulation of proliferation of bone marrow fibroblasts. Blood, 57, 781787.
  • Cattoretti, G., Schiro, R., Orazi, A., Soligo, D. & Colombo, M.P. (1993) Bone marrow stroma in humans: anti-nerve growth factor receptor antibodies selectively stain reticular cells in vivo and in vitro. Blood, 81, 17261738.
  • Chagraoui, H., Komura, E., Tulliez, M., Giraudier, S., Vainchenker, W. & Wendling, F. (2002) Prominent role of TGF-beta 1 in thrombopoietin-induced myelofibrosis in mice. Blood, 100, 34953503.
  • Chagraoui, H., Sabri, S., Capron, C., Villeval, J.L., Vainchenker, W. & Wendling, F. (2003a) Expression of osteoprotegerin mRNA and protein in murine megakaryocytes. Experimental Hematology, 31, 10811088.
  • Chagraoui, H., Tulliez, M., Smayra, T., Komura, E., Giraudier, S., Yun, T., Lassau, N., Vainchenker, W. & Wendling, F. (2003b) Stimulation of osteoprotegerin production is responsible for osteosclerosis in mice overexpressing TPO. Blood, 101, 29832989.
  • Clark, B.R. & Keating, A. (1995) Biology of bone marrow stroma. Annals of the New York Academy of Sciences, 770, 7078.
  • Coller, B.H., Hultin, M.B., Nurden, A.T., Rosa, J. & Lane, B.P. (1983) Isolated alpha-granule deficiency (gray platelet syndrom) with slight increase in bone marrow reticulin and possible glycoprotein and/or protease defect. Thrombosis and Haemostasis, 50, 211.
  • Dingli, D., Mesa, R.A. & Tefferi, A. (2004) Myelofibrosis with myeloid metaplasia: new developments in pathogenesis and treatment. Internal Medicine, 43, 540547.
  • Douglas, V.K., Tallman, M.S., Cripe, L.D. & Peterson, L.C. (2002) Thrombopoietin administered during induction chemotherapy to patients with acute myeloid leukemia induces transient morphologic changes that may resemble chronic myeloproliferative disorders. American Journal of Clinical Pathology, 117, 844850.
  • Drouet, L., Praloran, V., Cywiner-Golenzer, C., Trehen, C., Flandrin, G. & Caen, J.P. (1981) Deficit congenital en alpha granules plaquettaires et fibrose reticulinique medullaire. Nouvelle Revue Francaise d'Hematologie, 23, 95100.
  • Fakoya, F.A. (2002) Reticulin fibres in the tunica albuginea and peritubular tissue of seminiferous tubules of adult male Wistar rats. Acta Histochemica, 104, 279283.
  • Fava, R.A., Casey, T.T., Wilcox, J., Pelton, R.W., Moses, H.L. & Nanney, L.B. (1990) Synthesis of transforming growth factor-beta 1 by megakaryocytes and its localization to megakaryocyte and platelet alpha-granules. Blood, 76, 19461955.
  • Fleischmajer, R., Gay, S., Perlish, J.S. & Cesarini, J.P. (1980) Immunoelectron microscopy of type III collagen in normal and scleroderma skin. Journal of Investigative Dermatology, 75, 189191.
  • Fleischmajer, R., Jacobs, II, L., Perlish, J.S., Katchen, B., Schwartz, E. & Timpl, R. (1992) Immunochemical analysis of human kidney reticulin. American Journal of Pathology, 140, 12251235.
  • Frey, B.M., Rafii, S., Teterson, M., Eaton, D., Crystal, R.G. & Moore, M.A. (1998) Adenovector-mediated expression of human thrombopoietin cDNA in immune compromised mice: insights into the pathophysiology of osteomyelofibrosis. Journal of Immunology, 160, 691699.
  • Gomori, G. (1937) Silver impregnation of reticulum in paraffinsections. American Journal of Pathology, 13, 9931001.
  • Gomori, G. (1939) The effect of certain factors on the results of silver impregnation for reticulum fibers. American Journal of Pathology, 15, 493495.
  • Groopman, J.E. (1980) The pathogenesis of myelofibrosis in myeloproliferative disorders. Annals of Internal Medicine, 92, 857858.
  • Hann, I.M., Evans, D.I., Marsden, H.B., Jones, P.M. & Palmer, M.K. (1978) Bone marrow fibrosis in acute lymphoblastic leukaemia of childhood. Journal of Clinical Pathology, 31, 313315.
  • Harigaya, K., Cronkite, E.P., Miller, M.E. & Shadduck, R.K. (1981) Murine bone marrow cell line producing colony-stimulating factor. Proceedings of the National Academy of Science of the United States of America, 78, 69636966.
  • Hasselbalch, H., Junker, P., Lisse, I. & Bentsen, K.D. (1985) Serum procollagen III peptide in chronic myeloproliferative disorders. Scandinavian Journal of Haematology, 35, 550557.
  • Hasselbalch, H., Junker, P., Lisse, I., Bentsen, K.D., Risteli, L. & Risteli, J. (1986) Serum markers for type IV collagen and type III procollagen in the myelofibrosis-osteomyelosclerosis syndrome and other chronic myeloproliferative disorders. American Journal of Hematology, 23, 101111.
  • Hasselbalch, H., Junker, P., Horslev-Petersen, K., Lisse, I. & Bentsen, K.D. (1990) Procollagen type III aminoterminal peptide in serum in idiopathic myelofibrosis and allied conditions: relation to disease activity and effect of chemotherapy. American Journal of Hematology, 33, 1826.
  • Hasserjian, R.P., Boecklin, F., Parker, S., Chase, A., Dhar, S., Zaiac, M., Olavarria, E., Lampert, I., Henry, K., Apperley, J.F. & Goldman, J.M. (2002) ST1571 (imatinib mesylate) reduces bone marrow cellularity and normalizes morphologic features irrespective of cytogenetic response. American Journal of Clinical Pathology, 117, 360367.
  • Hussein, K., Brakensiek, K., Buesche, G., Buhr, T., Wiese, B., Kreipe, H. & Bock, O. (2007) Different involvement of the megakaryocytic lineage by the JAK2(V617F) mutation in polycythemia vera, essential thrombocythemia and chronic idiopathic myelofibrosis. Annals of Hematology, 86, 245253.
  • Ivanyi, J.L., Mahunka, M., Papp, A., Kiss, A. & Telek, B. (1994) Prognostic significance of bone marrow reticulin fibres in idiopathic myelofibrosis: evaluation of clinicopathological parameters in a scoring system. Haematologia, 26, 7586.
  • Johnston, J.B., Dalal, B.I., Israels, S.J., Oh, S., McMillan, E., Begleiter, A., Michaud, G., Israels, L.G. & Greenberg, A.H. (1995) Deposition of transforming growth factor-beta in the marrow in myelofibrosis, and the intracellular localization and secretion of TGF-beta by leukemic cells. American Journal of Clinical Pathology, 103, 574582.
  • Kerbauy, D.M., Gooley, T.A., Sale, G.E., Flowers, M.E., Doney, K.C., Georges, G.E., Greene, J.E., Linenberger, M., Petersdorf, E., Sandmaier, B.M., Scott, B.L., Sorror, M., Stirewalt, D.L., Stewart, F.M., Witherspoon, R.P., Storb, R., Appelbaum, F.R. & Deeg, H.J. (2007) Hematopoietic cell transplantation as curative therapy for idiopathic myelofibrosis, advanced polycythemia vera, and essential thrombocythemia. Biology of Blood and Marrow Transplantation, 13, 355365.
  • Kiernan, J.A. (1999) Histological and Histochemical Methods: Theory and Practice. Butterworth/Heinemann, Oxford.
  • Kimura, A., Katoh, O., Hyodo, H. & Kuramoto, A. (1989) Transforming growth factor-beta regulates growth as well as collagen and fibronectin synthesis of human marrow fibroblasts. British Journal of Haematology, 72, 486491.
  • Konstantopoulos, K., Terpos, E., Prinolakis, H., Kanta, A., Variami, E., Kanellopoulou, G., Vaiopoulos, G., Floros, A., Androulaki, A. & Meletis, J. (1998) Systemic lupus erythematosus presenting as myelofibrosis. Haematologia, 29, 153156.
  • Kuter, D.J. (2007) New thrombopoietic growth factors. Blood, 109, 46074616.
  • Kuter, D.J., Gminski, D.M. & Rosenberg, R.D. (1992) Transforming growth factor beta inhibits megakaryocyte growth and endomitosis. Blood, 79, 619626.
  • Kuter, D.J., Bussel, J., George, J.N., Aledort, L., Lichtin, A., Lyons, R., Nieva, J., Wasser, J.S., Bourgeois, E., Kappers-Klunne, M., Lefrere, F., Schipperus, M.R., Kelly, R., Christal, J., Guo, M. & Nichol, J.L. (2006) Long-term dosing of AMG 531 in thrombocytopenic patients with immune thrombocytopenic purpura: 48 week update. Blood, 108, 144a.
  • Lacout, C., Pisani, D.F., Tulliez, M., Gachelin, F.M., Vainchenker, W. & Villeval, J.L. (2006) JAK2V617F expression in murine hematopoietic cells leads to MPD mimicking human PV with secondary myelofibrosis. Blood, 108, 16521660.
  • Le Bousse-Kerdiles, M.C., Chevillard, S., Charpentier, A., Romquin, N., Clay, D., Smadja-Joffe, F., Praloran, V., Dupriez, B., Demory, J.L., Jasmin, C. & Martyre, M.C. (1996) Differential expression of transforming growth factor-beta, basic fibroblast growth factor, and their receptors in CD34+ hematopoietic progenitor cells from patients with myelofibrosis and myeloid metaplasia. Blood, 88, 45344546.
  • Lisse, I., Hasselbalch, H. & Junker, P. (1991) Bone marrow stroma in idiopathic myelofibrosis and other haematological diseases. An immunohistochemical study. APMIS, 99, 171178.
  • Lodish, H., Berk, A., Zipursky, L.S., Matsudaira, P., Baltimore, D. & Darnell, J. (2000) Molecular Cell Biology. W.H. Freeman, New York.
  • Lorand-Metze, I., Vassallo, J. & Souza, C.A. (1987) Histological and cytological heterogeneity of bone marrow in Philadelphia-positive chronic myelogenous leukaemia at diagnosis. British Journal of Haematology, 67, 4549.
  • Manoharan, A., Horsley, R. & Pitney, W.R. (1979) The reticulin content of bone marrow in acute leukaemia in adults. British Journal of Haematology, 43, 185190.
  • Martyre, M.C., Magdelenat, H., Bryckaert, M.C., Laine-Bidron, C. & Calvo, F. (1991) Increased intraplatelet levels of platelet-derived growth factor and transforming growth factor-beta in patients with myelofibrosis with myeloid metaplasia. British Journal of Haematology, 77, 8086.
  • Martyre, M.C., Romquin, N., Le Bousse-Kerdiles, M.C., Chevillard, S., Benyahia, B., Dupriez, B., Demory, J.L. & Bauters, F. (1994) Transforming growth factor-beta and megakaryocytes in the pathogenesis of idiopathic myelofibrosis. British Journal of Haematology, 88, 916.
  • McCarthy, D.M. (1985) Annotation. Fibrosis of the bone marrow: content and causes. British Journal of Haematology, 59, 17.
  • Mesa, R.A., Verstovsek, S., Cervantes, F., Barosi, G., Reilly, J.T., Dupriez, B., Levine, R., Le Bousse-Kerdiles, M.C., Wadleigh, M., Campbell, P.J., Silver, R.T., Vannucchi, A.M., Deeg, H.J., Gisslinger, H., Thomas, D., Odenike, O., Solberg, L.A., Gotlib, J., Hexner, E., Nimer, S.D., Kantarjian, H., Orazi, A., Vardiman, J.W., Thiele, J. & Tefferi, A. (2007) Primary myelofibrosis (PMF), post polycythemia vera myelofibrosis (post-PV MF), post essential thrombocythemia myelofibrosis (post-ET MF), blast phase PMF (PMF-BP): Consensus on terminology by the international working group for myelofibrosis research and treatment (IWG-MRT). Leukemia Research, 31, 737740.
  • Montes, G.S., Krisztan, R.M., Shigihara, K.M., Tokoro, R., Mourao, P.A. & Junqueira, L.C. (1980) Histochemical and morphological characterization of reticular fibers. Histochemistry, 65, 131141.
  • O'Malley, D.P., Sen, J., Juliar, B.E. & Orazi, A. (2005) Evaluation of stroma in human immunodeficiency virus/acquired immunodeficiency syndrome-affected bone marrows and correlation with CD4 counts. Archives of Pathology & Laboratory Medicine, 129, 11371140.
  • Ohkawa, H. & Harigaya, K. (1987) Effect of direct cell-to-cell interaction between the KM-102 clonal human marrow stromal cell line and the HL-60 myeloid leukemic cell line on the differentiation and proliferation of the HL-60 line. Cancer Research, 47, 28792882.
  • Orazi, A., Cattoretti, G., Schiro, R., Siena, S., Bregni, M., Di Nicola, M. & Gianni, A.M. (1992) Recombinant human interleukin-3 and recombinant human granulocyte-macrophage colony-stimulating factor administered in vivo after high-dose cyclophosphamide cancer chemotherapy: effect on hematopoiesis and microenvironment in human bone marrow. Blood, 79, 26102619.
  • Orazi, A., Cooper, R.J., Tong, J., Gordon, M.S., Battiato, L., Sledge, Jr, G.W., Kaye, J.A., Kahsai, M. & Hoffman, R. (1996) Effects of recombinant human interleukin-11 (Neumega rhIL-11 growth factor) on megakaryocytopoiesis in human bone marrow. Experimental Hematology, 24, 12891297.
  • Pagliuca, A., Layton, D.M., Manoharan, A., Gordon, S., Green, P.J. & Mufti, G.J. (1989) Myelofibrosis in primary myelodysplastic syndromes: a clinico-morphological study of 10 cases. British Journal of Haematology, 71, 499504.
  • Pereira, R.M., Velloso, E.R., Menezes, Y., Gualandro, S., Vassalo, J. & Yoshinari, N.H. (1998) Bone marrow findings in systemic lupus erythematosus patients with peripheral cytopenias. Clinical Rheumatology, 17, 219222.
  • Popat, U., Frost, A., Liu, E., May, R., Bag, R., Reddy, V. & Prchal, J.T. (2005) New onset of myelofibrosis in association with pulmonary arterial hypertension. Annals of Internal Medicine, 143, 466467.
  • Popat, U., Frost, A., Liu, E., Guan, Y., Durette, A., Reddy, V. & Prchal, J.T. (2006) High levels of circulating CD34 cells, dacrocytes, clonal hematopoiesis, and JAK2 mutation differentiate myelofibrosis with myeloid metaplasia from secondary myelofibrosis associated with pulmonary hypertension. Blood, 107, 34863488.
  • Puchtler, H. (1964) On the original definition of the term ‘‘Reticulin’’. Journal of Histochemistry and Cytochemistry, 12, 552.
  • Puchtler, H. & Waldrop, F.W. (1978) Silver impregnation methods for reticulum fibers and reticulin: a re-investigation of their origins and specificity. Histochemistry, 57, 177187.
  • Pullarkat, V., Bass, R.D., Gong, J.Z., Feinstein, D.I. & Brynes, R.K. (2003) Primary autoimmune myelofibrosis: definition of a distinct clinicopathologic syndrome. American Journal of Hematology, 72, 812.
  • Rameshwar, P., Denny, T.N., Stein, D. & Gascon, P. (1994) Monocyte adhesion in patients with bone marrow fibrosis is required for the production of fibrogenic cytokines. Potential role for interleukin-1 and TGF-beta. Journal of Immunology, 153, 28192830.
  • Reilly, J.T., Nash, J.R., Mackie, M.J. & McVerry, B.A. (1985) Immuno-enzymatic detection of fibronectin in normal and pathological haematopoietic tissue. British Journal of Haematology, 59, 497504.
  • Roberts, A.B., McCune, B.K. & Sporn, M.B. (1992) TGF-beta: regulation of extracellular matrix. Kidney International, 41, 557559.
  • Rocha Filho, F.D., Ferreira, F.V., Mendes Fde, O., Ferreira, F.N., Karbage, A., Alencar, M.L. & Costa, D. (2000) Bone marrow fibrosis (pseudo-myelofibrosis) in human kala-azar. Revista da Sociedada Brasileira de Medicina Tropical, 33, 363366.
  • Sale, G.E., Deeg, H.J. & Porter, B.A. (2006) Regression of myelofibrosis and osteosclerosis following hematopoietic cell transplantation assessed by magnetic resonance imaging and histologic grading. Biology of Blood and Marrow Transplantation, 12, 12851294.
  • Shehata, M., Schwarzmeier, J.D., Hilgarth, M., Hubmann, R., Duechler, M. & Gisslinger, H. (2004) TGF-beta1 induces bone marrow reticulin fibrosis in hairy cell leukemia. Journal of Clinical Investigation, 113, 676685.
  • Stepan, D., Sergis-Deavenport, E., Kelly, R., Christal, J., Chen, C. & Nichol, J. (2005) Safety profile of AMG 531 in healthy volunteers and in thrombocytopenic patients with immune thrombocytopenic purpura. Blood, 106, 361a.
  • Stevens, A. & Lowe, J. (2000) Pathology. Mosby, New York.
  • Sudo, T., Ito, M., Ogawa, Y., Iizuka, M., Kodama, H., Kunisada, T., Hayashi, S., Ogawa, M., Sakai, K. & Nishikawa, S. (1989) Interleukin 7 production and function in stromal cell-dependent B cell development. Journal of Experimental Medicine, 170, 333338.
  • Tefferi, A. (2000) Myelofibrosis with myeloid metaplasia. New England Journal of Medicine, 342, 12551265.
  • Tefferi, A. (2005) Pathogenesis of myelofibrosis with myeloid metaplasia. Journal of Clinical Oncology, 23, 85208530.
  • Tefferi, A. (2006) Classification, diagnosis and management of myeloproliferative disorders in the JAK2V617F era. Hematology: American Society of Hematology Educational Program, 108, 240245.
  • Tefferi, A., Barosi, G., Mesa, R.A., Cervantes, F., Deeg, H.J., Reilly, J.T., Verstovsek, S., Dupriez, B., Silver, R.T., Odenike, O., Cortes, J., Wadleigh, M., Solberg, Jr, L.A., Camoriano, J.K., Gisslinger, H., Noel, P., Thiele, J., Vardiman, J.W., Hoffman, R., Cross, N.C., Gilliland, D.G. & Kantarjian, H. (2006) International Working Group (IWG) consensus criteria for treatment response in myelofibrosis with myeloid metaplasia, for the IWG for Myelofibrosis Research and Treatment (IWG-MRT). Blood, 108, 14971503.
  • Tefferi, A., Thiele, J., Orazi, A., Kvasnicka, H.M., Barbui, T., Hanson, C.A., Barosi, G., Verstovsek, S., Birgegard, G., Mesa, R., Reilly, J.T., Gisslinger, H., Vannucchi, A.M., Cervantes, F., Finazzi, G., Hoffman, R., Gilliland, D.G., Bloomfield, C.D. & Vardiman, J.W. (2007) Proposals and rationale for revision of the World Health Organization diagnostic criteria for polycythemia vera, essential thrombocythemia, and primary myelofibrosis: recommendations from an ad hoc international expert panel. Blood, 110, 10921107.
  • Terui, T., Niitsu, Y., Mahara, K., Fujisaki, Y., Urushizaki, Y., Mogi, Y., Kohgo, Y., Watanabe, N., Ogura, M. & Saito, H. (1990) The production of transforming growth factor-beta in acute megakaryoblastic leukemia and its possible implications in myelofibrosis. Blood, 75, 15401548.
  • Thiele, J. & Kvasnicka, H.M. (2006) Grade of bone marrow fibrosis is associated with relevant hematological findings-a clinicopathological study on 865 patients with chronic idiopathic myelofibrosis. Annals of Hematology, 85, 226232.
  • Thiele, J., Grashof, K. & Fisher, R. (1991) Follow-up study on bone marrow reticulin fibrosis in AML. Analytical Cellular Pathology, 3, 225231.
  • Thiele, J., Kvasnicka, H.M., Facchetti, F., Franco, V., Van Der Walt, J. & Orazi, A. (2005) European consensus on grading bone marrow fibrosis and assessment of cellularity. Haematologica, 90, 11281132.
  • Udomsakdi-Auewarakul, C., Visuthisakchai, S., Sangruchi, T. & Issaragrisil, S. (2003) Reversal of marrow fibrosis in agnogenic myeloid metaplasia by allogeneic peripheral blood stem cell transplantation. Asian Pacific Journal of Allergy and Immunology, 21, 121126.
  • Ushiki, T. (2002) Collagen fibers, reticular fibers and elastic fibers. A comprehensive understanding from a morphological viewpoint. Archives of Histology and Cytology, 65, 109126.
  • Wagner-Ballon, O., Chagraoui, H., Prina, E., Tulliez, M., Milon, G., Raslova, H., Villeval, J.L., Vainchenker, W. & Giraudier, S. (2006) Monocyte/macrophage dysfunctions do not impair the promotion of myelofibrosis by high levels of thrombopoietin. Journal of Immunology, 176, 64256433.
  • Wang, B., Nichol, J.L. & Sullivan, J.T. (2004) Pharmacodynamics and pharmacokinetics of AMG 531, a novel thrombopoietin receptor ligand. Clinical Pharmacology and Therapeutics, 76, 628638.
  • Watanabe, Y. (1985) Fine structure of bone marrow stroma. Nippon Ketsueki Gakkai Zasshi - Acta Haematologica Japonica, 48, 16881700.
  • Weiss, L. & Chen, L.T. (1975) The organization of hematopoietic cords and vascular sinuses in bone marrow. Blood Cells, 1, 617.
  • Wernig, G., Mercher, T., Okabe, R., Levine, R.L., Lee, B.H. & Gilliland, D.G. (2006) Expression of Jak2V617F causes a polycythemia vera-like disease with associated myelofibrosis in a murine bone marrow transplant model. Blood, 107, 42744281.
  • Wolf, B.C. & Neiman, R.S. (1985) Myelofibrosis with myeloid metaplasia: pathophysiologic implications of the correlation between bone marrow changes and progression of splenomegaly. Blood, 65, 803809.
  • Yanagida, M., Ide, Y., Imai, A., Toriyama, M., Aoki, T., Harada, K., Izumi, H., Uzumaki, H., Kusaka, M. & Tokiwa, T. (1997) The role of transforming growth factor-beta in PEG-rHuMGDF-induced reversible myelofibrosis in rats. British Journal of Haematology, 99, 739745.
  • Zaleskas, V.M., Krause, D.S., Lazarides, K., Patel, N., Hu, Y., Li, S. & Van Etten, R.A. (2006) Molecular pathogenesis and therapy of polycythemia induced in mice by JAK2 V617F. PLoS ONE, 1, e18.
  • Zhang, Y., Adachi, Y., Suzuki, Y., Minamino, K., Iwasaki, M., Hisha, H., Song, C.Y., Kusafuka, K., Nakano, K., Koike, Y., Wang, J., Koh, E., Cui, Y., Li, C. & Ikehara, S. (2004) Simultaneous injection of bone marrow cells and stromal cells into bone marrow accelerates hematopoiesis in vivo. Stem Cells, 22, 12561262.